$KZR Kezar Life Sciences, Inc. Insider Trading
Get free email notifications about insider trading in Kezar Life Sciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kezar Life Sciences, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Kezar Life Sciences, Inc. for free.
CIK Number: 0001645666
IRS Number: 473366145
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: KZR
Company Address: 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO 94080
Phone number: 650-463-4052
Kezar Life Sciences, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 29 2021 | KZR | Kezar Life Science ... | Economides Vassiliki | SVP, Strategy & Ext ... | Buy | P | 10.19 | 750 | 7,643 | 11,320 | 10.6 K to 11.3 K (+7.10 %) |
Jan 11 2021 | KZR | Kezar Life Science ... | Fowler John Franklin | CEO | Option Exercise | A | 5.45 | 1,200,000 | 6,540,000 | 1,200,000 | |
Jan 11 2021 | KZR | Kezar Life Science ... | Economides Vassiliki | SVP, Strategy & Ext ... | Option Exercise | A | 5.45 | 110,000 | 599,500 | 110,000 | |
Jan 11 2021 | KZR | Kezar Life Science ... | Belsky Marc | CFO | Option Exercise | A | 5.45 | 220,000 | 1,199,000 | 220,000 | |
Jan 11 2021 | KZR | Kezar Life Science ... | Kirk Christopher J. | President and CSO | Option Exercise | A | 5.45 | 260,000 | 1,417,000 | 260,000 | |
Jan 11 2021 | KZR | Kezar Life Science ... | Kirk Christopher J. | President and CSO | Option Exercise | A | 5.45 | 260,000 | 1,417,000 | 260,000 | |
Jan 11 2021 | KZR | Kezar Life Science ... | Henig Noreen | Chief Medical Offic ... | Option Exercise | A | 5.45 | 280,000 | 1,526,000 | 280,000 | |
Jan 04 2021 | KZR | Kezar Life Science ... | Fowler John Franklin | CEO | Option Exercise | M | 0.90 | 16,000 | 14,400 | 90,421 | |
Jan 04 2021 | KZR | Kezar Life Science ... | Fowler John Franklin | CEO | Buy | M | 0.90 | 16,000 | 14,400 | 359,204 | 343.2 K to 359.2 K (+4.66 %) |
Jun 26 2020 | KZR | Kezar Life Science ... | COOPER GRAHAM K | Director | Option Exercise | A | 5.60 | 8,896 | 49,818 | 8,896 | |
Jun 26 2020 | KZR | Kezar Life Science ... | Dinges Jason | Director | Option Exercise | A | 5.60 | 8,896 | 49,818 | 8,896 | |
Jun 26 2020 | KZR | Kezar Life Science ... | Kauffman Michael | Director | Option Exercise | A | 5.60 | 8,896 | 49,818 | 8,896 | |
Jun 26 2020 | KZR | Kezar Life Science ... | Sommadossi Jean-Pierre | Director | Option Exercise | A | 5.60 | 8,896 | 49,818 | 8,896 | |
Jun 26 2020 | KZR | Kezar Life Science ... | BERGER FRANKLIN M | Director | Option Exercise | A | 5.60 | 8,896 | 49,818 | 8,896 | |
Jun 26 2020 | KZR | Kezar Life Science ... | Garner Elizabeth | Director | Option Exercise | A | 5.60 | 8,896 | 49,818 | 8,896 |